The records of 2 013 patients who underwent RP and intraoperative frozen section (IFS) analysis between July 2007 and June 2016 were reviewed. IFS analysis of the urethra and bladder neck was performed, and if malignant or atypical cells remained, further resection with the aim of achieving histological negativity was carried out. Patients were divided into three groups according to the findings: those with a negative surgical margin (NSM), a positive surgical margin converted to negative (NCSM) and a persistent positive surgical margin (PSM).
Introduction
Intra-operative frozen section (IFS) analysis is a common procedure in general surgical pathology practice. IFS analysis enables identification of the surgical margin status during radical prostatectomy (RP) for prostate cancer. In cases with a positive IFS, further tissue resection is often performed to achieve conversion to a histologically negative margin. Some suggest, however, that IFS analysis during RP is not justifiable because it has low sensitivity, meaning that a significant proportion of positive margins would be missed with this technique [1, 2] . In addition, further resection of soft tissue with tumour involvement of the posterolateral or anterior prostate is often difficult.
We routinely perform IFS analysis of the soft tissue margin at the urethra and bladder neck, where the demarcation of the prostate is not distinct, regardless of the margin status of the prostatectomy specimen. Further removal of the tissue surrounding the urethra or bladder neck is a much easier procedure than removing tissue at the neurovascular bundle area or posterolateral aspect of the prostate.
The aim of the present study was to assess the impact of conversion from histologically positive to negative soft tissue margins at the apex and bladder neck on both biochemical recurrence-free survival (BCRFS) and distant metastasis-free survival (DMFS) after RP for prostate cancer. In addition, we aimed to identify the appropriate indications for performing IFS analysis when striving to achieve a conversion of the surgical margin from histologically positive to negative during RP.
Materials and Methods

Study Subjects
The records of 2 242 patients who underwent RP by an experienced surgeon (H.A.) at the Asan Medical Centre between July 2007 and June 2016 were reviewed. Patients who had received neoadjuvant or adjuvant therapy, were node-positive, had inadequate clinical data or lacked IFS analysis were excluded. After exclusions, 2 013 patients were enrolled. The study protocol was approved by the hospital institutional review board.
The patients' PSA levels were assessed after surgery at 3-monthly intervals for the first 2 years, every 6 months for the third and fourth years, and annually thereafter. The median follow-up duration for enrolled patients was 61.3 months. Biochemical recurrence was defined as two consecutive rises in PSA level of ≥0.2 ng/mL after RP.
To identify the effects of converting the surgical margin from histologically positive to negative, patients were divided into three groups based on the surgical margin status as follows: negative surgical margin (NSM), positive surgical margin converted to negative (NCSM) and positive surgical margin (PSM) groups. The NCSM group included patients with a PSM at the inked specimen, but with a final negative IFS at the site of the PSM and with a NSM elsewhere.
Frozen Section Analysis and Pathological Examination
Frozen biopsies of the urethra and bladder neck soft tissues were performed intra-operatively. If malignant or atypical cells were present on the IFS, further tissue resection at this site was performed until a negative IFS was achieved, except in cases where the soft tissue margin was persistently positive on IFS despite two additional resections, when further tissue resection was suspended. The complete IFS procedure requires an average of 15 min and, at the Asan Medical Centre, costs approximately US$70.
Whole-mount section processing has been described previously [3] . Briefly, both the apex and base of the prostate were examined using the cone method with sagittal sectioning of the tissue sample. After routine fixation, the remaining specimen was sectioned transversely through the major axis at 3-to 5-mm intervals. Each slice was either prepared for microscopic examination on whole-mount slides or divided and split between two slides. Sections were fixed in formalin and processed for paraffin embedding according to routine protocols. All prostate blocks were site-specifically labelled. All pathology slides were reviewed by expert genitourinary pathologists. The PSM was defined as tumour extending to the inked surface of the specimen. The definitive surgical margin status was determined on the whole RP specimen, and analysis of each IFS from the resection margins was reported separately.
Statistical Analysis
Clinical and pathological data were expressed as frequencies and means. In study groups, differences were assessed by Student's t test for continuous variables and by the chisquared test for categorical variables. Kaplan-Meier curves with the log rank test were used to evaluate the impact of surgical margin conversion from positive to negative on survival outcomes. Multivariate analysis using the Cox proportional hazard model with a stepwise backwards elimination approach was performed to identify significant prognostic factors. All statistical tests were two-tailed with a significance level of 0.05. All statistical analyses were performed using SPSS version 21.0 (IBM, Armonk, NY, USA).
Results
Clinical and pathological characteristics are summarized in Table 1 . The overall PSM rate was 24.9%. When analysed according to pathological stage, the PSM rates were 10.8% in pT2, 36.6% in pT3a and 52.7% in pT3b disease. IFS analyses were initially negative in 1 799 patients, converted to negative in 139 patients, and were persistently positive in 75 patients. Among 1 799 patients with initially negative IFS, PSMs at the negative IFS site were found in 49 patients (2.7%). When the results of IFS and permanent specimen analyses were compared, the sensitivity, specificity, negative predictive value and positive predictive value of IFS analysis were 78.1%, 97.8%, 97.3% and 81.8%, respectively.
The overall 5-year BCRFS rates of patients in the NSM, NCSM and PSM groups were 89.6%, 85.1% and 57.1%, respectively (P < 0.001; Fig. 1 ). According to pathological 812 © 2018 The Authors BJU International © 2018 BJU International stage, the 5-year BCRFS rates of patients with pT2 cancers in the NSM, NCSM and PSM groups were 93.8%, 94.8% and 72.5%, respectively (P < 0.001), and 77.9%, 70.1% and 49.9%, respectively, in patients with pT3 cancer (P < 0.001). No significant difference in BCRFS rates was noted between the patients in the NCSM and the NSM groups with either pT2 (P = 0.800) or pT3 (P = 0.380) cancers.
The overall 7-year DMFS rates of patients in the NSM, NCSM and PSM groups were 97.8%, 99.1% and 89.4%, respectively (P < 0.001; Fig. 2 ). Among those with pT2 cancers, no significant difference was found in the 7-year DMFS rates among the patients in the NSM, NCSM and PSM groups (98.6%, 100% and 96.9%, respectively; P = 0.616); however, among those with pT3 cancers, the 7-year DMFS rates of patients in the NSM and NCSM groups were significantly higher than those of patients in the PSM group (95.7%, 98% and 86.7%, respectively; P = 0.023).
To identify the patients likely to benefit from conversion from a positive to a negative soft tissue margin, we analysed the BCRFS rates according to the National Comprehensive Cancer Network risk group classification (Fig. 3 ). The NCSM group had similar 5-year BCRFS rates to those observed in NSM group among patients with low-(96.3% vs 95.8%; P = 0.752) and intermediate-risk disease (91.1% vs 82.8%; P = 0.291), but the rate for the NCSM group was significantly lower than for the NSM group among patients with high-risk disease (73.2% vs 54.7%; P = 0.042).
In multivariate analysis (Table 2) , NCSM status (hazard ratio 0.624, P = 0.033) was an independent predictor of biochemical recurrence along with PSA, pathological Gleason score and pT stage; however, NCSM status was not significantly associated with distant metastasis (P = 0.254; Table 3 ). IFS, intra-operative frozen section; NCSM, positive surgical margin converted to negative; NSM, negative surgical margin; PSM, positive surgical margin. 
Discussion
Positive surgical margins after RP are not uncommon and are thought to be an independent predictor of disease recurrence [4] . Accurate assessment of margin status during RP is therefore important in clinical practice.
In the present study, the overall PSM rate was 25%, which was higher than has been observed in previous studies [5] . The large proportion of patients with pT3 (pT3a, 27.7%; pT3b, 8.3%) and high grade tumours (Gleason score 8-10, 13.5%), as well as those classified as high risk (23.4%), among the study cohort could account for this relatively high PSM rate. The stage-specific PSM rates in the present study were 10.8% for pT2 and 40.3% for pT3 disease, and are similar to those in previous studies [5] .
During RP, IFS analysis is performed for evaluating margin status, evaluating optimization of nerve-sparing and determining lymph node status [6] . A wide range in sensitivity and specificity of IFS analysis has been reported (sensitivity, 21-96%; specificity, 86-100%) [7] . Tsuboi et al. (c) High-risk disease.
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© 2018 The Authors BJU International © 2018 BJU International [2] reported an IFS analysis sensitivity of 42%; in 55 patients with PSMs, only 23 patients had a positive IFS. By contrast, other studies showed IFS analysis to be highly sensitive (>90%) [8, 9] . IFS analysis in the present study had a relatively high sensitivity of 78.1% and a specificity of 97.8%.
There is no consensus regarding the appropriate sites or clinical indications for IFS [10] . Lepor and Kaci reported that IFS analysis of apical prostate soft tissue is beneficial [11] . With involvement of the posterolateral aspects, some show that IFS analysis significantly reduces the PSM rate [8, 9, 12] , whereas others do not [13, 14] .
In a few studies comparing outcomes after RP with and without IFS, IFS was associated with a marginally lower risk of biochemical recurrence after RP [8, 15] . In the present study period, 107 of 2 242 patients underwent RP without IFS analysis. The overall 5-year BCRFS rate of patients who did not undergo IFS analysis was lower than that of patients with NSMs (72.3% vs 89.6%, P < 0.001) and NCSMs (72.3% vs 85.1%, P = 0.061) who underwent IFS analysis. When surgical margin status was taken into consideration, patients with NSMs who did not undergo IFS analysis had a lower 5-year BCRFS rate than those with NSMs who underwent IFS analysis (74.4% vs 89.6%, P < 0.001). The overall 5-year BCRFS rate of patients with PSMs who did not undergo IFS analysis was lower than that of patients with PSMs who underwent IFS analysis, but without statistical significance (47.6% vs 57.1%, P = 0.555).
Although many studies have evaluated the utility of IFS in reducing PSMs, only a few have assessed the effects of converting margins from positive to negative on oncological outcomes, and these have had mixed results (Table 4) . Rabbani et al. [16] found that the 3-year BCRFS of patients HR, hazard ratio; NCSM, positive surgical margin converted to negative; NSM, negative surgical margin; PSM, positive surgical margin. with NCSMs was similar to that of patients with NSMs; however, in other studies [17, 18] , conversion to a negative status did not show a statistically significant benefit with regard to BCRFS. With involvement at the urethral margin, Ye et al. [19] reported that the BCRFS was better in patients with a positive urethral margin that was resected to negativity than in those in whom it persisted. In two recent studies examining the conversion of a positive posterolateral margin [8, 12] , the BCRFS of patients rendered negative in the neurovascular bundle area did not differ from that of patients with an initial NSM.
In the present study, IFS analysis and conversion of the soft tissue margin at the prostate apex and bladder neck to negativity improved the 5-year BCRFS for patients with pT2 and pT3 prostate cancers. On multivariate analysis, those in the NCSM group had a significantly reduced risk of biochemical recurrence, which is in line with other wellknown factors associated with a better prognosis. Although the impact of PSMs on distant metastasis or cancer-specific mortality is controversial [4] , the present study showed that, among those with pT3 cancers, patients with a PSM rendered negative by further resection had a better 7-year DMFS rate than those in the PSM group, but this was the same as that of patients in the NSM group (Fig. 3c) ; however, the conversion of the PSM to negativity was not an independent predictor associated with the incidence of distant metastasis.
We routinely perform IFS analysis of the soft tissue margins at the apex and bladder neck, where there is no fibromuscular band of the prostate. Initially, positive IFS was found at the apex in 140 patients (7.0%), at the base in 63 patients (3.1%) and at both in 11 patients (0.5%). Among these patients, margin conversion to negativity was achieved in 87 patients (62.1%) at the apex and 43 (74.6%) at the bladder neck. The margin conversion rate was lower in the apex than in the base, because drastic resection is limited at the apex owing to concerns over incontinence. For patients in the NCSM group, no significant difference in the 5-year BCRFS rates was found between the apex and bladder neck soft tissue margin conversion to negativity (Fig. S1) . We perform IFS analysis at the neurovascular bundle area only when extraprostatic extension is grossly suspected. In the present study, conversion of the surgical margin to negative in the posterolateral aspect was achieved in four patients. None of these patients had biochemical recurrence during a median follow-up of 55.6 months. We did not routinely perform IFS along the neurovascular bundle because the identification of the exact soft tissue location contiguous to the PSM on the posterolateral aspect of the prostate is often difficult. Furthermore, random IFS biopsies taken at the neurovascular bundle may not be representative [17] , and thorough IFS analysis in this area may be a time-consuming and costly process.
In the present study, survival benefits of converting the soft tissue margin from positive to negative were observed only in the low-and intermediate-risk disease groups, and not in the high-risk disease group (Fig. 3) . The inherent tumour biology rather than the margin status may be the major determinant of disease recurrence in high-risk prostate cancer; however, the 5-year BCRFS of patients with a PSM converted to negativity was similar to that of patients with an NSM with clinical (c)T2 high-risk prostate cancer (85.7% vs 80.7%; P = 0.448; [Fig. S2]) . Increasingly, MRI is being considered as an important diagnostic tool for the detection, staging and treatment planning of prostate cancer. A recent study showed MRI was effective in identifying apical significant prostate cancer [20] . In this study, multiparametric MRI based on the Prosate Imaging Reporting and Data System (PI-RADS) was performed in 508 patients, which revealed that a positive apical IFS was more frequent in patients with PI-RADS category 5 lesions at the apex (PI-RADS category 1-3: 7.8%; PI-RADS category 4: 7.1%; PI-RADS category 5:14.4%; P = 0.041). Similarly, positive basal IFS was more frequently found in patients with PI-RADS category 5 lesions at the base (PI-RADS category 1-3: 0.4%; PI-RADS category 4: 1.7%; PI-RADS category 5: 5.6% [P = 0.003]). These results suggest preoperative MRI may be helpful in selecting patients who might benefit from IFS analysis and further resection of PSMs.
The present study has some limitations. First, as mentioned above, we did not confirm or compare the oncological benefit of IFS analysis and conversion to the negativity of sites representative of the whole prostate, including the posterolateral aspect. Second, the follow-up duration was insufficient to evaluate radiographic progression or overall survival. Third, the cost-effectiveness of the IFS analysis was not considered. Despite these limitations, we believe that this study is valuable because it is the first large cohort study with long-term follow-up to report the oncological benefit of converting soft tissue surgical margins at the apex and bladder neck from histologically positive to negative during RP. Conversion of soft tissue margins at the prostate apex and bladder neck from histologically positive to negative improved the BCRFS and DMFS after RP for prostate cancer. Rendering PSMs negative by further resection may help to decrease the risk of biochemical recurrence in patients with low-and intermediate-risk prostate cancer; that there was any benefit for high-risk cancers was, however, not apparent.
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